| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jun 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 0 | 9,293 | 0.00 | 73,738 |
| 19 Mar 24 | ALEC Alector | Common Stock | Grant | Acquire A | No | No | 0 | 41,250 | 0.00 | 41,250 |
| 19 Mar 24 | ALEC Alector | Stock Option Common Stock | Grant | Acquire A | No | No | 6.2 | 19,420 | 120.40 k | 19,420 |
| 30 Nov 23 | CYCN Cyclerion Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
| 30 Nov 23 | CYCN Cyclerion Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 50,000 |
